Your search for comorbidities returned 61 results

Researchers theorized that disparities between the sexes in the management of MI had changed over time, altering the prognoses after MI, especially the risk for heart failure.

Researchers assessed the risk for obstructive sleep apnea (OSA) among patients with type 2 diabetes and cardiovascular disease taking empagliflozin and further examined the effect of OSA on metabolic, cardiovascular, and renal outcomes.

Arterial lactate levels 8 hours after cardiogenic shock were found to be a better parameter for mortality risk prediction than lactate clearance or baseline lactate.

Decompensation severity may be associated with increased risk for adverse clinical outcomes post-hospital discharge in patients with first-episode acute heart failure.

Quality of care and in-hospital mortality were found to be comparable for patients with heart failure who were covered by Medicare Advantage or fee-for-service Medicare.

Serum levels of magnesium may not be associated with arrhythmia burden in older adults.

Levels of a set of circulating biomarkers were found to be elevated in patients with HFpEF.

A position statement by the Canadian Cardiovascular Society/Canadian Thoracic Society outlines recommendations for the detection, care, and treatment of pulmonary hypertension.

Valve-in-valve transcatheter aortic valve replacement had superior short-term outcomes than redo surgical aortic valve replacement, but comparable long-term outcomes.

An algorithm that uses routine clinical values was able to accurately predict heart failure subphenotypes.